LifeCycle Pharma initiates enrollment in Phase III kidney transplant trial
The clinical trial protocol has been reviewed by the FDA, and LifeCycle Pharma (LCP) expects to enroll approximately 300 stable kidney transplant patients in the program. The study
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.